205 related articles for article (PubMed ID: 17214346)
1. Carcinosarcomas--a retrospective analysis of 21 patients.
Villena-Heinsen C; Diesing D; Fischer D; Griesinger G; Maas N; Diedrich K; Friedrich M
Anticancer Res; 2006; 26(6C):4817-23. PubMed ID: 17214346
[TBL] [Abstract][Full Text] [Related]
2. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of 12 cases of uterine carcinosarcoma].
Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L
Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
5. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
[TBL] [Abstract][Full Text] [Related]
6. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
[TBL] [Abstract][Full Text] [Related]
7. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcomes of uterine and ovarian carcinosarcoma.
Jonson AL; Bliss RL; Truskinovsky A; Judson P; Argenta P; Carson L; Dusenbery K; Downs LS
Gynecol Oncol; 2006 Mar; 100(3):561-4. PubMed ID: 16271748
[TBL] [Abstract][Full Text] [Related]
9. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
10. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
11. A comparison between different postoperative treatment modalities of uterine carcinosarcoma.
Menczer J; Levy T; Piura B; Chetrit A; Altaras M; Meirovitz M; Glezerman M; Fishman A
Gynecol Oncol; 2005 Apr; 97(1):166-70. PubMed ID: 15790453
[TBL] [Abstract][Full Text] [Related]
12. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
[TBL] [Abstract][Full Text] [Related]
13. Malignant mixed Mullerian tumours of the uterus--a ten-year experience.
Ho SP; Ho TH
Singapore Med J; 2002 Sep; 43(9):452-6. PubMed ID: 12568422
[TBL] [Abstract][Full Text] [Related]
14. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
[TBL] [Abstract][Full Text] [Related]
15. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
16. Cervical carcinosarcoma: a case report.
Abidi A; Menn K; Sherman A; Konia T; Azodi M
J Reprod Med; 2008 Feb; 53(2):138-40. PubMed ID: 18357808
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma.
Galaal K; Kew FM; Tam KF; Lopes A; Meirovitz M; Naik R; Godfrey KA; Hatem MH; Edmondson RJ
Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):88-92. PubMed ID: 19201517
[TBL] [Abstract][Full Text] [Related]
18. [Twenty-two cases of uterine carcinosarcomas].
Giraudet G; Collinet P; Farine MO; Narducci F; Poncelet E; Baranzelli MC; Vinatier D
J Gynecol Obstet Biol Reprod (Paris); 2011 Feb; 40(1):22-8. PubMed ID: 21112160
[TBL] [Abstract][Full Text] [Related]
19. Cervical sarcomas: an analysis of incidence and outcome.
Wright JD; Rosenblum K; Huettner PC; Mutch DG; Rader JS; Powell MA; Gibb RK
Gynecol Oncol; 2005 Nov; 99(2):348-51. PubMed ID: 16051326
[TBL] [Abstract][Full Text] [Related]
20. Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?
Raspollini MR; Susini T; Amunni G; Paglierani M; Castiglione F; Garbini F; Carriero C; Scarselli G; Taddei GL
Int J Gynecol Cancer; 2006; 16(1):416-22. PubMed ID: 16445668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
